Study guide
Depression assessment and treatment
AMC CAT MCQ Examination AMC Part 1
Track your progress as you read
Finished sections get a check mark.
1 Acute Coronary Syndromes & ECG Localization
ACS recognition and ECG localisation Reperfusion and infarction complications
2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias
Heart failure assessment and treatment Arrhythmias and conduction emergencies
3 Systemic Hypertension & Peripheral Vascular Disease
Blood pressure and cardiovascular risk Secondary hypertension and arterial disease
4 Valvular Heart Disease, Infective Endocarditis & Pericarditis
Aortic and mitral valve disease Endocarditis and pericardial emergencies
5 Asthma & COPD Acute Flares and Maintenance
Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations
6 Pneumonia, pleural disease and respiratory failure
Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis
7 GI bleeding, bowel inflammation and malabsorption
GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS
8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis
Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance
9 Diabetes, thyroid and adrenal disease
Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease
10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies
AKI and chronic kidney disease Potassium and sodium emergencies
11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment
Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care
12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis
Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia
13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology
Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms
14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis
Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment
15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries
Trauma primary survey and adjuncts Chest trauma and immediate threats
16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance
Head injury, imaging and haemorrhage Herniation and spinal cord injury
17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome
Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury
18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care
Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus
19 Aortic Aneurysms & Acute Arterial Limb Ischaemia
Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia
20 Urological Emergencies, Testicular Torsion & Haematuria Investigation
Retention, stones and obstructed infection Scrotal pain and haematuria
21 Preoperative Risk Stratification & Postoperative Surgical Complications
Preoperative assessment and medicines Postoperative complications and prevention
22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening
Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons
23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy
Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding
24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies
Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth
25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis
Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care
26 Contraception, Emergency Contraception & Pregnancy Termination
Contraceptive choice and missed pills Emergency contraception and abortion
27 Australian Cervical Screening Program & Gynaecological Malignancies
Cervical screening and cervical cancer Endometrial and ovarian cancer
28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice
Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening
29 Developmental Milestones, Growth Charts & Failure to Thrive
Developmental milestones Regression, autism and support Faltering growth and developmental comparisons
30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions
Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons
31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis
Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis
32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease
Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up
33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury
Pyloric stenosis Intussusception and dehydration Child protection and injury assessment
34 The Mental State Examination & Suicide Risk Stratification
Mental state examination and psychotic symptoms Suicide formulation and mental health law
35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT
36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder
Anxiety, panic and agoraphobia OCD and trauma-related disorders
37 Schizophrenia, Acute Psychosis & Antipsychotic Management
Psychosis assessment and antipsychotics Clozapine and severe adverse effects
38 Substance Use Disorders & Acute Withdrawal Syndromes
Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants
39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry
Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry
40 Medicare, PBS, AHPRA & Good Medical Practice Framework
Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications
41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment
Consent, material risks and young people Capacity, refusal and substitute decisions
42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications
Privacy, disclosure and child reporting Driving fitness and threat disclosure
43 First Nations health and preventive care
First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention
44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases
Epidemiology, calculations, bias and surveillance
45 Neurological presentations
Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness
46 Musculoskeletal pain
Back, neck, bone and soft tissue pain
47 Eye presentations
Altered vision and retinal disease Red eye, ocular injury and discharge
48 Ear, nose, throat and oral health
Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis
49 Skin, hair and nails
Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities
50 Breast health and feeding
Breast lumps, discharge and breastfeeding problems
51 Sexual and reproductive presentations
Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction
52 Palliative care and carers
The dying patient, symptoms and carers
53 Eating disorders and personality care
Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care
54 Sleep presentations
Insomnia, snoring and daytime sleepiness
55 Poisoning, resuscitation and environmental emergencies
Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning
56 Communication, rights and professional practice
Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health
57 Genetics, research and donation
Genetic testing, research and organ donation
58 Travel, fever and outbreaks
Fever, travellers and outbreak response
Depression assessment and treatment
Key Takeaways Explain This Topic AI
Ask about previous mania or hypomania before treating apparent unipolar depression.
SSRIs require monitoring for adverse effects and clinical response.
Psychological therapy is an important treatment option.
Last updated: October 2026
Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers
Mood disorders represent the leading cause of non-fatal disease burden in Australian clinical medicine. Under guidelines published by the Royal Australian and New Zealand College of Psychiatrists (RANZCP), medical practitioners must master diagnostic phenotyping, pharmacological titration, adverse effect surveillance, and somatic interventions across the depressive and bipolar spectrum.
Major Depressive Disorder (MDD)
Major Depressive Disorder is a severe, recurring psychiatric illness characterized by persistent disturbances in affect, cognitive processing, vegetative neurobiology, and interpersonal functioning.
Diagnostic Criteria (DSM-5)
A definitive diagnosis of Major Depressive Disorder requires at least 5 of the following 9 symptoms present during the same 2-week period , representing a clear change from prior baseline functioning. Crucially, at least one of the symptoms must be either (1) depressed mood or (2) loss of interest or pleasure (anhedonia) .
Clinical Phenotypes and Subtypes
Melancholic / Biological Depression : Characterized by profound vegetative disturbance: anhedonia that is unreactive to positive events, a distinct quality of depressed mood (felt as physical anguish or emptiness), diurnal variation (regularly worse in the early morning), terminal insomnia (awakening at least 2 hours before normal waking time), marked psychomotor retardation or agitation, significant anorexia, and excessive guilt. Highly responsive to biological therapies (SSRIs, SNRIs, tricyclics, ECT).
Atypical Depression : Characterized by preserved mood reactivity (mood brightens transiently in response to positive stimuli), leaden paralysis (heavy, lead-like sensation in arms or legs), reversed vegetative signs (hyperphagia with carbohydrate craving, hypersomnia), and long-standing interpersonal rejection sensitivity.
Psychotic Depression : Depressive episodes complicated by hallucinations or delusions. Psychotic themes are usually mood-congruent (delusions of worthlessness, guilt, financial ruin, severe incurable somatic illness, or Cotard nihilistic delusions). Psychotic depression requires combination therapy with an antidepressant plus an atypical antipsychotic, or urgent Electroconvulsive Therapy (ECT) , as antidepressant monotherapy has unacceptably high failure rates.
Assessment and Screening Tools in Australian Practice
Kessler Psychological Distress Scale (K10) : A 10-item questionnaire measuring psychological distress over the past 4 weeks. Heavily embedded in the Australian Medicare system for initiating and reviewing General Practice Mental Health Treatment Plans (MHTP under Better Access).
Patient Health Questionnaire-9 (PHQ-9) : A 9-item scale directly mapping onto the 9 DSM-5 criteria, utilized for grading depression severity (mild: 5–9, moderate: 10–14, moderately severe: 15–19, severe: 20–27) and monitoring longitudinal treatment response.
Pharmacotherapy of Depression: Assessment and treatment principles
For mild depression, low-intensity psychological strategies (structured physical exercise, sleep hygiene, online CBT such as MoodGYM or MindSpot) are first-line. For moderate to severe MDD, pharmacotherapy combined with evidence-based psychotherapy (Cognitive Behavioural Therapy or Interpersonal Psychotherapy) is the gold standard.
First-Line Antidepressants: SSRIs & SNRIs
Selective Serotonin Reuptake Inhibitors (SSRIs) :
First-line choices: Sertraline ( 50 to 200 mg 50\text{ to }200\text{ mg} 50 to 200 mg daily) and Escitalopram ( 10 to 20 mg 10\text{ to }20\text{ mg} 10 to 20 mg daily).
Antidepressant choice: Sertraline is often suitable in cardiac disease or breastfeeding, but no agent is universally safest for every patient. Review indication, interactions, prior response and perinatal advice.
Escitalopram is highly selective but carries a dose-dependent risk of QTc prolongation ; maximum dose is capped at 20 mg 20\text{ mg} 20 mg daily ( 10 mg 10\text{ mg} 10 mg daily in adults aged ≥ 65 years \ge 65\text{ years} ≥ 65 years ).
Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs) :
Agents: Venlafaxine ( 75 to 225 mg 75\text{ to }225\text{ mg} 75 to 225 mg daily) and Duloxetine ( 30 to 60 mg 30\text{ to }60\text{ mg} 30 to 60 mg daily).
Particularly effective in melancholic depression, severe refractory depression, and depression comorbid with chronic neuropathic pain.
Noradrenergic activation can cause dose-dependent hypertension; baseline and regular blood pressure monitoring is mandatory.
Key Adverse Effects & Clinical Management
Gastrointestinal Symptoms : Nausea, loose stools, and dyspepsia occur early due to stimulation of peripheral 5-HT3 receptors; usually self-limiting within 7 to 14 days.
Sexual Dysfunction : Reduced libido, erectile dysfunction, delayed ejaculation, and anorgasmia occur in up to 30% to 50% of patients and typically persist throughout treatment. Management includes dose reduction, switching to non-serotonergic agents (such as mirtazapine or agomelatine), or adding a PDE-5 inhibitor.
Hyponatraemia / SIADH : Caused by inappropriate ADH release, particularly in elderly patients, those on concurrent thiazide diuretics, or those with low baseline sodium. Serum electrolytes must be checked at baseline and 2 to 4 weeks after initiation in older adults.
Bleeding Risk : Platelets take up serotonin from plasma to facilitate aggregation. SSRIs deplete platelet serotonin, doubling the risk of upper gastrointestinal bleeding. Co-prescription with NSAIDs, aspirin, or oral anticoagulants requires gastroprotection with a proton pump inhibitor.
Black-Box Suicidality Warning : In children, adolescents, and young adults under 25 years of age, initiation of SSRIs/SNRIs can induce a paradoxical transient surge in agitation, akathisia, and suicidal thoughts during the first 1 to 2 weeks before therapeutic mood elevation occurs. Close weekly clinical review is mandatory during early titration.
Therapeutic Trial Duration & Discontinuation
Adequate Trial : A minimum of 4 to 6 weeks at an established therapeutic dose is required to judge clinical efficacy. If no improvement is observed at 4 weeks, titrate to the maximum tolerated dose or switch to another first-line class.
Maintenance Duration : Following complete symptomatic remission, antidepressant therapy must continue for at least 6 to 12 months for a first depressive episode to prevent relapse. For recurrent depression ( ≥ 2 \ge 2 ≥ 2 or 3 lifetime episodes), maintenance therapy is recommended for at least 2 to 5 years , or indefinitely.
Stopping antidepressants: Taper collaboratively according to drug, duration, dose and withdrawal symptoms. Some patients need a much slower taper over months. Distinguish withdrawal from relapse and adjust the plan rather than enforcing a universal four-to-eight-week schedule.
Primary references (checked 7 October 2026): EXTRIP lithium recommendations .